Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AAAP NASDAQ:IRON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAAAPAdvanced Accelerator Applications$81.63$0.00$35.11▼$82.74N/AN/AN/AN/AIRONDisc Medicine$59.00-3.0%$54.58$30.82▼$68.73$2.11B0.77366,477 shs407,269 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAAAPAdvanced Accelerator Applications0.00%0.00%0.00%0.00%0.00%IRONDisc Medicine-3.01%-0.59%+10.53%+33.21%+40.11%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAAAPAdvanced Accelerator ApplicationsN/AN/AN/AN/AN/AN/AN/AN/AIRONDisc Medicine3.4418 of 5 stars4.53.00.00.02.72.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAAAPAdvanced Accelerator Applications 0.00N/AN/AN/AIRONDisc Medicine 3.08Buy$95.7362.25% UpsideCurrent Analyst Ratings BreakdownLatest AAAP, BSFA, RGO, and IRON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/21/2025IRONDisc MedicineWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$90.007/21/2025IRONDisc MedicineTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$86.007/3/2025IRONDisc MedicineMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$85.007/3/2025IRONDisc MedicineHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$118.006/17/2025IRONDisc MedicineHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$118.006/16/2025IRONDisc MedicineWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$90.006/11/2025IRONDisc MedicineRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageStrong-Buy$89.005/12/2025IRONDisc MedicineBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$112.00 ➝ $120.00(Data available from 8/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAAAPAdvanced Accelerator ApplicationsN/AN/AN/AN/AN/AN/AIRONDisc MedicineN/AN/AN/AN/A$14.85 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAAAPAdvanced Accelerator ApplicationsN/AN/A0.00∞N/AN/AN/AN/AN/AIRONDisc Medicine-$109.36M-$3.92N/AN/AN/AN/A-22.61%-21.07%8/14/2025 (Estimated)Latest AAAP, BSFA, RGO, and IRON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025IRONDisc Medicine-$1.17N/AN/AN/AN/AN/A5/7/2025Q1 2025IRONDisc Medicine-$0.99-$1.02-$0.03-$1.02N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAAAPAdvanced Accelerator ApplicationsN/AN/AN/AN/AN/AIRONDisc MedicineN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAAAPAdvanced Accelerator ApplicationsN/AN/AN/AIRONDisc Medicine0.0437.6537.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAAAPAdvanced Accelerator ApplicationsN/AIRONDisc Medicine83.70%Insider OwnershipCompanyInsider OwnershipAAAPAdvanced Accelerator ApplicationsN/AIRONDisc Medicine4.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAAAPAdvanced Accelerator ApplicationsN/AN/AN/ANot OptionableIRONDisc Medicine3034.63 million33.17 millionNot OptionableAAAP, BSFA, RGO, and IRON HeadlinesRecent News About These CompaniesDisc Medicine (IRON) Expected to Announce Earnings on Thursday2 hours ago | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Disc Medicine, Inc. (NASDAQ:IRON)August 5 at 6:28 AM | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 8,492 Shares of StockAugust 2, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director Sells $518,351.68 in StockAugust 2, 2025 | insidertrades.comDisc Medicine, Inc. (IRON) Set to Submit NDA for Bitopertin in October 2025July 28, 2025 | finance.yahoo.comBank of New York Mellon Corp Buys 6,242 Shares of Disc Medicine, Inc. (NASDAQ:IRON)July 27, 2025 | marketbeat.comKevin Bitterman Sells 13,033 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockJuly 26, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 29,837 Shares of StockJuly 26, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 13,033 Shares of StockJuly 26, 2025 | insidertrades.comVictory Capital Management Inc. Reduces Position in Disc Medicine, Inc. (NASDAQ:IRON)July 25, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director Sells $40,590.32 in StockJuly 23, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 664 Shares of StockJuly 23, 2025 | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of "Buy" by BrokeragesJuly 23, 2025 | marketbeat.comDisc Medicine's (IRON) "Outperform" Rating Reaffirmed at WedbushJuly 21, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Coverage Initiated at Truist FinancialJuly 21, 2025 | marketbeat.comDisc Medicine, Inc. Receives Positive FDA Feedback for Bitopertin NDA Submission in Erythropoietic ProtoporphyriaJuly 21, 2025 | quiverquant.comQRaymond James Reaffirms Their Buy Rating on Disc Medicine (IRON)July 20, 2025 | theglobeandmail.comDisc Medicine, Inc. (NASDAQ:IRON) CFO Jean M. Franchi Sells 2,031 SharesJuly 19, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) CFO Sells 2,031 Shares of StockJuly 19, 2025 | insidertrades.comBristol Myers drug fails main goal in cancer-linked anemia trialJuly 18, 2025 | msn.comBristol Myers' drug fails main goal in cancer-related anemia trialJuly 18, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Super Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 2025View Super Micro Computer Sees Unusual Volume—Catalyst Ahead?This Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025View This Drone Stock Is on Sale Despite Big Army Contract3 Discounted Steel Stocks You Can DCA Into TodayBy Gabriel Osorio-Mazilli | July 26, 2025View 3 Discounted Steel Stocks You Can DCA Into TodayAAAP, BSFA, RGO, and IRON Company DescriptionsAdvanced Accelerator Applications NASDAQ:AAAPAdvanced Accelerator Applications S.A. is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer. The Company has a portfolio of nine diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. PET and SPECT are imaging techniques in molecular nuclear diagnostics (MND) with applications in clinical oncology, cardiology, neurology and inflammatory/infectious diseases. Its commercial products include Gluscan/Gluscan 500/Barnascan, FluoroChol, MIBITEC/Adamibi, DOPAVIEW, Leukokit, Neurolite, SomaKit and NETSPOT. Additional MND product candidates include Annexin V-128, a SPECT product candidate for the imaging of apoptotic and necrotic lesions with potential applications in a range of indications.Disc Medicine NASDAQ:IRON$59.00 -1.83 (-3.01%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$59.06 +0.06 (+0.11%) As of 08/6/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Joby Deal Gives Blade New Direction, But Stock Lacks Lift How DigitalOcean's Focus Is Fueling Explosive Growth Disney’s Iger-Led Turnaround Gains Traction Can Celsius Stock Keep Its Momentum Going Any Longer? AMD’s Results Sparked a Sell-Off—But That’s Your Buy Signal Rivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline Does Broadcom Have a VMware Problem? Goldman Eyes Upside in NTNX RSI Stock Soars 22% On Q2 Blowout—Will PENN Match the Momentum? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
